The strong growth of revenue and the decline in net profit decreased by nearly 50 %.

Text/Yang Jianyong

In the first half of 2022, Haier's biological revenue was 1.268 billion yuan, an increase of 36.63%year -on -year; net profit was 300 million yuan, a year -on -year decrease of 47.55%. The reason for increasing the income and increasing profit is that the disposal of the joint venture MESA last year was related to the one -time non -recurring profit and loss. In the same period last year, the investment income generated by long -term equity investment was as high as 379 million. If the 17.11%equity confirmation and disposal income of MESA, which was sold in the same period last year, was deleted, the net profit growth of net profit and non -deductive net profit after deduction was still stable, respectively, an increase of 36.89%and 41%year -on -year, respectively.

It should be pointed out that the significant increase in revenue is to adhere to the user -centric scene ecological strategy, and actively expand the digital scenario solutions: the two major fields of life science and medical innovation. The Internet of Things solution business and traditional business have maintained high growth. Among them, the IoT solution achieved revenue of 487 million yuan in the first half of the year, an increase of 109.68%year -on -year, accounting for a total income ratio to 38.43%, showing a strong growth trend.

As a traditional manufacturer of low -temperature storage equipment in biomedical medical care, in today's digital and intelligent transformation and upgrading, Haier Biological is the main line of the Internet of Things, allowing this traditional enterprise to rejuvenate. On the whole, Haier Biological focuses on life science and medical innovation and medical innovation. In the field, we attach great importance to the integration of new generation of information technology and industry, and pioneered the comprehensive solution of the Internet of Things scenario. At the same time, through the upgrading of the Internet of Things solution and the layout of multiple products, users with two major fields of life science and medical innovation provide comprehensive digital scenario solutions, thereby strengthening the overall competitive advantage.

Specifically, in the field of life sciences, Haier Biological IoT sample management solutions realize the three -way real -time interaction of people, machines, and samples, and combined with automation and other technologies to achieve the automation and unmannedization of the entire process of the sample entry and in -depth database. , Intelligent management, greatly improving the accuracy and work efficiency of sample access management, and promoted the change of sample management; further innovating the comprehensive solution of the smart laboratory scene scene, while achieving the interconnection of the Internet of Things equipment The real -time safety of the environment has promoted the digital change of the laboratory.

In the field of medical innovation, the intelligent blood management plan of the Internet of Things with blood scenarios has realized the interconnection of blood stations and hospitals in urban center center, upgrading the original centralized blood supply to a distributed blood supply mode; the smart public health scene covers the smart vaccine Solution such as vaccination, biological safety nucleic acid samples, and digital public health examinations help the upgrade of the grass -roots medical and health system.

物联网场景方案不仅推动了行业的升级变革，更为重要的是，依托物联网方案公司得以与用户零距离交互，通过增值服务拓展用户新需求，支持从“产品”到“场景方案”、从The "one -sex product transaction" to the "continuous value -added service" model upgrades, creating the lifelong value of users, while laying the foundation for Haier creatures to become a digital scene ecological brand, it also opened up room for performance growth.

In the first half of 2022, the revenue of the life science sector was 626 million yuan, an increase of 63%year -on -year. Due to the enrichment of the plan, it continued to expand towards the entire scene of the smart laboratory. The IoT scenario solution under the sector achieved a revenue of 172 million yuan, an increase of 169.58%year -on -year. In the medical innovation sector, in the first half of 2022, revenue was 636 million yuan, a year -on -year increase of 21.35%. Among them, the IoT scenario solution under the sector realized revenue of 316 million yuan, an increase of 87.1%year -on -year. It is worth mentioning that the growth rate of overseas markets is also very eye -catching, mainly because it is time to grasp the needs of extensive overseas users, and it is upgraded by single products to scene plan models. In the first half of the year, revenue from overseas market revenue reached 356 million yuan, an increase of 50.52%year -on -year.

Judging from the data disclosed by the semi -annual financial report, the Internet of Things scenario plan has become an important driving factor for Haier's growth in biological performance. In the first half of the year, the IoT solution business continued to deepen the landing and achieved revenue of 487 million yuan, which further increased the proportion of revenue to 38.43%with a revenue increase of 109.68%. The two major sectors of life sciences and medical innovations achieved income of 172 million yuan and 316 million yuan, respectively, an increase of 169.58%and 87.1%year -on -year. The Internet of Things plan is double growth, and the proportion will continue to increase, indicating that the transformation effect of the Internet of Things will be further emerged.

Finally, the Internet of Things has shown a booming situation in the past few years. All sectors have actively used new technologies such as artificial intelligence, cloud computing, and the Internet of Things to drive the intelligent transformation of industries, bringing new opportunities for companies that actively promote the transformation of the Internet of Things. As one of the representative manufacturers facing the Internet of Things direction, Haier Bio has transformed into a comprehensive biological security solution service provider based on the Internet of Things transformation. The comprehensive solution represented by smart vaccine vaccination, and further extended to digital hospitals, smart laboratories and other scenarios to further meet the needs of user information, automation, and intelligence on the basis of meeting user storage needs. And driven by factors such as the rapid replication of the Internet of Things scenario solution, the expansion of the global market competition advantages, and the continuous introduction of innovative product solutions, it has brought about high -speed growth in revenue and profitability.

Yang Jianyong, a Forbes Chinese writer, is committed to in -depth interpretation of cutting -edge technologies such as the Internet of Things, cloud services and artificial intelligence.

- END -